The discussion focuses on the changing landscape of treatment for mutated acute myeloid leukemia (AML). The speaker emphasizes the significance of mutation profiles in AML patients, which can have prognostic or therapeutic implications. Poultry inhibitors are believed to have a lasting impact, with many candidates already approved or under investigation.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
The session’s agenda involves a brief introduction followed by experts discussing various aspects of mutated AML. Current diagnostic methods include assessing morphology, flow cytometry, fish, cytogenetics, and mutation profiles.
Prominent mutations include Flt3, IDH, NPM1, and TP53 mutations.